---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-011195"
form_type: "8-K"
ticker: "IRIX"
cik: "0001006045"
company_name: "IRIDEX CORP"
filed_at: "2022-03-21T23:59:59+00:00"
generated_at: "2026-06-26T21:14:06.279643+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Iridex appoints Beverly Huss to board, expanding from five to six members

## Summary
- Appointment effective March 17, 2022; board size increased from 5 to 6.
- Ms. Huss received a nonstatutory stock option for 15,000 shares vesting monthly over 4 years.
- She brings over 25 years of medical device management and board experience.
- Currently CEO of Pagonia Medical; former CEO of Qool Therapeutics and Guidant executive.

## SEC filing metadata
- accession: 0001564590-22-011195
- form_type: 8-K
- ticker: IRIX
- cik: 0001006045
- company_name: IRIDEX CORP
- filed_at: 2022-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006045/000156459022011195/0001564590-22-011195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006045/000156459022011195/irix-8k_20220321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-011195
- JSON: https://secwatch.observer/filing/0001564590-22-011195.json
- Plain text: https://secwatch.observer/filing/0001564590-22-011195.txt

## Key facts
- Executive change
  Beverly A. Huss was appointed as Director at IRIDEX CORP.
  - Action: appointed
  - Role: Director
  source text: On March 17, 2022, Iridex Corporation (the “ Company ”) appointed Beverly A. Huss to its board of directors (the “ Board ”), effective March 17, 2022 (the “ Effective Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006045/000156459022011195/0001564590-22-011195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.